Three new fungicide co-formulations approved and launched in the UK
ADAMA has launched three new fungicide co-formulations in the UK. All three products contain the active ingredient prothioconazole, with two also...
MAXENTIS® - Simple, flexible and effective disease control this spring
This season, make disease control easier with MAXENTIS, the versatile, two-in-one fungicide designed to fit seamlessly into your spray programme....
Powering up disease control at T3 with prothioconazole
With unsettled weather continuing to favour disease development, attention turns to protecting the ear. As such, the T3 fungicide timing will be...
Unique PTZ formulation enhances cereal disease control
The unique formulation of ADAMA’s prothioconazole based fungicides delivers improved control of a range of stem-base, foliar and ear diseases...
How to maximise the efficacy of fungicide programmes with the inclusion of ARIZONA (500g/l folpet)
As a result of the winter’s wet conditions, there’s already a significant amount of disease present in those cereals which were drilled early. If...
Powering up the performance of prothioconazole at T3
Prothioconazole is widely used against a range of cereal and oilseed rape diseases, but not all brands of this generic active ingredient are...
Unique prothioconazole formulation boosts disease control
The unique formulation used in both of ADAMA’s prothioconazole fungicides, SORATEL® and MAGAN®, offers improved control of a range of stem-base,...
Kickstart wheat disease control with an early fungicide
This year’s wet, and predominantly mild, winter has resulted in plenty of disease pressure, especially in those wheat crops which were drilled...
Unique prothioconazole formulation boosts disease control at T3
ADAMA’s prothioconazole fungicide, SORATEL, uses a unique formulation to offer improved disease control at T3.
T2: the optimum time to protect against ramularia
Even though conditions have remained largely dry in recent weeks, and the majority of winter barley crops look relatively clean, it is still...